Transaction in Own Shares

21st Nov 2024 07:00

RNS Number : 0337N
Octopus Renewables Infra Trust PLC
21 November 2024
 

21 November 2024

 

LEI: 213800B81BFJKWM2JV13

 

Octopus Renewables Infrastructure Trust plc

 

("ORIT" or the "Company")

 

Transaction in Own Shares

 

The Company announces that in accordance with the authority granted at the Company's Annual General Meeting held on 19 June 2024, it purchased on 20 November 2024, 80,000 ordinary shares of one pence each in the capital of the Company ("Ordinary Shares") at an average price of 72.6 pence per share. These shares will be held by the Company in treasury.

 

Following this transaction, the Company holds 6,769,380 Ordinary Shares in treasury and has 564,927,536 Ordinary Shares in issue, including those in treasury. Therefore, the total number of voting rights in the Company is 558,158,156 and accordingly that figure may be used by shareholders as the denominator for calculations of interests in the Company's voting rights in accordance with the FCA's Disclosure Guidance and Transparency Rules.

 

Details of this transaction are as follows:

 

Date of purchase:

20/11/2024

Aggregate number of Ordinary Shares purchased:

80,000

Lowest price paid per share (GBp):

72.6

Highest price paid per share (GBp):

72.6

Volume weighted average price paid per share (GBp):

72.6

 

 

Number of Ordinary Shares purchased

Transaction price (GBp)

Trading Venue

 80,00

72.6

XLON

 

 

For further information please contact:

 

Octopus Energy Generation (Investment Manager)

Chris Gaydon, David Bird

 

Via Burson Buchanan

Peel Hunt (Broker)

Liz Yong, Luke Simpson, Huw Jeremy (Investment Banking)

Alex Howe, Chris Bunstead, Ed Welsby, Richard Harris, Michael Bateman (Sales)

 

020 7418 8900

Burson Buchanan (Financial PR)

Charles Ryland, Verity Parker, Samuel Adams

 

020 7466 5000

Apex Listed Companies Services (UK) Limited (Company Secretary)

020 3327 9720

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFEMFWSELSEFF